Longtime Hutchmed CEO Hogg departs, handing over the reins amid US expansion plans
Just as Chinese drugmaker Hutchmed looks to make its big break in the US, the longtime helmsman who brought it to this point is making his exit.
Hutchmed CEO Christian Hogg will step down Friday from the role he has held for 15 years, handing over the reins to Weiguo Su, a 17-year veteran of Hutchmed himself, the company said in a release.
Hogg, who joined Hutchmed nearly 22 years ago before transitioning into the CEO role in 2007, will retire to move back to Europe and attend “important family responsibilities,” according to a statement.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 153,900+ biopharma pros reading Endpoints daily — and it's free.